Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2019 1
2020 1
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Current progress in the treatment of metaplastic breast carcinoma.
Hu Q, Chen WX, Zhong SL, Li J, Luo Z, Tang JH, Zhao JH. Hu Q, et al. Asian Pac J Cancer Prev. 2013;14(11):6221-5. doi: 10.7314/apjcp.2013.14.11.6221. Asian Pac J Cancer Prev. 2013. PMID: 24377508 Free article. Review.
Metaplastic breast cancer (MBC) is a rare type of breast carcinoma, characterized by various combinations of mesenchymal, adenocarcinoma and other epithelial components. ...In clinical practice, MBC is usually treated based on the guidelines developed …
Metaplastic breast cancer (MBC) is a rare type of breast carcinoma, characterized by various combinations of mes …
Best Practice (Efficient) Immunohistologic Panel for Diagnosing Metaplastic Breast Carcinoma.
Han M, Zhang H, Dabbs DJ. Han M, et al. Appl Immunohistochem Mol Morphol. 2021 Apr 1;29(4):265-269. doi: 10.1097/PAI.0000000000000873. Appl Immunohistochem Mol Morphol. 2021. PMID: 32858538
Immunohistochemistry (IHC) plays a key role in the diagnosis of metaplastic breast carcinomas (MBCs), particularly the spindle cell variant. ...
Immunohistochemistry (IHC) plays a key role in the diagnosis of metaplastic breast carcinomas (MBCs), particularly the spindle …
Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management.
Rakha EA, Quinn CM, Foschini MP, Muñoz Martin M, Dabbs DJ, Lakhani S, Varga Z, Pinder SE, Schmitt FC, Reis-Filho JS, Fox SB, Ellis IO, Tan PH, Mihai R. Rakha EA, et al. Histopathology. 2021 Apr;78(5):759-771. doi: 10.1111/his.14290. Epub 2020 Dec 16. Histopathology. 2021. PMID: 33113154 Free PMC article.
This study aimed to provide an evidence-based approach to improve the consistency of diagnosis and management for such cases. METHODS AND RESULTS: A large series (n = 140) of metaplastic breast carcinoma (MBC) diagnosed in Nottingham over 18 years was analyse …
This study aimed to provide an evidence-based approach to improve the consistency of diagnosis and management for such cases. METHODS AND RE …
Clinical and Demographic Factors, Treatment Patterns, and Overall Survival Associated With Rare Triple-Negative Breast Carcinomas in the US.
Elimimian EB, Samuel TA, Liang H, Elson L, Bilani N, Nahleh ZA. Elimimian EB, et al. JAMA Netw Open. 2021 Apr 1;4(4):e214123. doi: 10.1001/jamanetworkopen.2021.4123. JAMA Netw Open. 2021. PMID: 33844001 Free PMC article.
OBJECTIVE: To present the clinical and demographic characteristics, treatment patterns, and overall survival (OS) for histologically rare (<10% of breast cancers) triple-negative breast cancer types: medullary carcinoma, adenoid cystic carcinoma, an …
OBJECTIVE: To present the clinical and demographic characteristics, treatment patterns, and overall survival (OS) for histologically rare (& …
Survival and treatment outcomes of metaplastic breast carcinoma: Single tertiary care center experience in Pakistan.
Samoon Z, Beg M, Idress R, Jabbar AA. Samoon Z, et al. Indian J Cancer. 2019 Apr-Jun;56(2):124-129. doi: 10.4103/ijc.IJC_731_18. Indian J Cancer. 2019. PMID: 31062730 Free article.
BACKGROUND: Metaplastic breast carcinoma (MBC) is a rare disease with incidence of less than 1%. ...
BACKGROUND: Metaplastic breast carcinoma (MBC) is a rare disease with incidence of less than 1%. ...
Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.
Ross JS, Badve S, Wang K, Sheehan CE, Boguniewicz AB, Otto GA, Yelensky R, Lipson D, Ali S, Morosini D, Chliemlecki J, Elvin JA, Miller VA, Stephens PJ. Ross JS, et al. Arch Pathol Lab Med. 2015 May;139(5):642-9. doi: 10.5858/arpa.2014-0200-OA. Arch Pathol Lab Med. 2015. PMID: 25927147 Free article.
CONTEXT: Metastatic metaplastic breast carcinoma (MPBC) is an uncommon, but aggressive, tumor resistant to conventional chemotherapy. OBJECTIVE: To learn whether next-generation sequencing could identify potential targets of therapy for patients with r …
CONTEXT: Metastatic metaplastic breast carcinoma (MPBC) is an uncommon, but aggressive, tumor resistant to conventional …